Ci
Cirius Therapeutics
Kalamazoo MIFounded 201630 employees
Private CapbiotechAcquiredHepatology
Platform: FXR NASH
Market Cap
N/A
All Drugs
3
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zorizumab | CIR-5679 | Phase 1 | 1 | DLL3 | SCLC | ||
| Capilemzoparlimab | CIR-7549 | Phase 2 | 2 | VEGF | PBCBladder Ca | ||
| CIR-5071 | CIR-5071 | Phase 2 | 1 | CGRP | MS |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (4)